Cowen And Company, LLC Homology Medicines, Inc. Transaction History

Cowen And Company, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$9.94 - $16.59 $1.31 Million - $2.18 Million	-131,633 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$12.07 - $19.34 $4.16 Million - $6.67 Million	-344,855 Reduced 72.37%	131,633 $2 Million
Q1 2020 May 11, 2020	BUY	$12.5 - $22.04 $5.96 Million - $10.5 Million	476,488 New	476,488 $7.41 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.